AIMMUNE THERAPEUTICS INC - COM (AIMT)

Historical Holders from Q3 2015 to Q4 2020

Symbol
AIMT
Type / Class
Equity / COM
All holders as of 31 Dec 2020
Q4 2020
Total 13F shares, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-176
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of AIMMUNE THERAPEUTICS INC - COM (AIMT)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2020 Q4 0 $0 -$1,499,050,881 0
2020 Q3 43,543,534 $1,499,962,663 +$140,947,867 $34.45 180
2020 Q2 49,339,027 $824,462,207 +$27,617,409 $16.71 159
2020 Q1 47,814,937 $684,558,740 -$26,663,745 $14.42 150
2019 Q4 46,897,696 $1,569,666,220 -$56,484,265 $33.47 149
2019 Q3 52,031,455 $1,089,570,102 +$59,135,623 $20.94 142
2019 Q2 49,209,231 $1,024,396,221 +$28,894,644 $20.82 122
2019 Q1 47,852,332 $1,069,499,392 +$40,278,975 $22.35 123
2018 Q4 45,941,687 $1,098,891,390 +$30,175,470 $23.92 132
2018 Q3 44,487,374 $1,213,626,892 -$52,697,964 $27.28 138
2018 Q2 46,420,501 $1,248,272,218 -$14,125,420 $26.89 146
2018 Q1 46,414,550 $1,475,382,616 +$290,333,730 $31.83 148
2017 Q4 37,285,807 $1,409,999,138 -$55,448,638 $37.82 123
2017 Q3 37,281,723 $924,868,486 +$10,811,295 $24.79 95
2017 Q2 36,834,954 $757,321,487 +$33,867,907 $20.56 92
2017 Q1 35,054,647 $761,820,800 +$90,569,995 $21.73 86
2016 Q4 33,071,678 $676,319,830 +$56,203,015 $20.45 90
2016 Q3 30,279,345 $454,194,890 +$38,539,453 $15.00 71
2016 Q2 28,267,055 $305,850,641 +$4,284,694 $10.82 71
2016 Q1 27,540,546 $373,663,068 +$23,658,168 $13.56 68
2015 Q4 25,774,476 $475,537,051 +$5,077,938 $18.45 57
2015 Q3 21,755,078 $550,829,286 +$550,829,286 $25.32 58